Cases & Deals

  • Home
  • Practices
  • Theranexus completes €7.8 million rights issue

Share

Theranexus completes €7.8 million rights issue

November 2025

Client(s) Theranexus SAS

Jones Day represented Theranexus SAS, a pharmaceutical company specializing in rare neurological diseases, listed on Euronext Growth Paris, in connection with its €7.8 million rights issue of new shares.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.